Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Silver Creek Pharmaceuticals
AddedFeb 15, 2024
UpdatedJun 18, 2026
Silver Creek Pharmaceuticals

Silver Creek Pharmaceuticals

Inactive

Silver Creek Pharmaceuticals: Developing protein therapeutics for cardiovascular diseases and stroke treatment.

HQ
San Francisco, CA, US
Founded
2010
Overview
Compare
Fundraising
Employees
Website

Silver Creek Pharmaceuticals, founded with a mission to address cardiovascular diseases, focuses on developing protein therapeutics to treat organ damage resulting from acute injuries. Their core product, SCP776, is currently undergoing clinical trials for stroke treatment. The company aims to revolutionize stroke recovery and cardiovascular health through innovative biotechnological solutions.

Notable figures in the company include leading experts in biotechnology and cardiovascular research. Silver Creek Pharmaceuticals has garnered attention from prominent investors in the biotech sector, reflecting confidence in their groundbreaking approach. Their key achievements include advancing SCP776 into clinical trials, marking significant progress in stroke treatment. The company's impact lies in its potential to improve recovery outcomes for stroke patients and contribute to advancements in cardiovascular therapeutics.

Silver Creek Pharmaceuticals - Similar Companies

Stream Biomedical logo

Stream Biomedical

Stoke Therapeutics logo

Stoke Therapeutics

Sequel Pharmaceuticals logo

Sequel Pharmaceuticals

sequelpharma.com

United Therapeutics logo

United Therapeutics

Osprey Pharmaceuticals USA logo

Osprey Pharmaceuticals USA

ospreypharma.com

Stemedica Cell Technologies logo

Stemedica Cell Technologies

stemedica.com

Chase Therapeutics logo

Chase Therapeutics

Corridor Pharmaceuticals logo

Corridor Pharmaceuticals

CinRx Pharma logo

CinRx Pharma

cinrx.com

Sinapis Pharma logo

Sinapis Pharma

Clear Creek Bio logo

Clear Creek Bio

clearcreekbio.com

CeleCor Therapeutics logo

CeleCor Therapeutics

celecor.com

Underdog Pharmaceuticals logo

Underdog Pharmaceuticals

cyclaritytx.com

Riparian Pharmaceuticals logo

Riparian Pharmaceuticals

Castle Creek Biosciences logo

Castle Creek Biosciences

Silver Creek Pharmaceuticals - Quick Facts

Who are Silver Creek Pharmaceuticals' competitors?

Companies similar to Silver Creek Pharmaceuticals include Stream Biomedical, Stoke Therapeutics, Sequel Pharmaceuticals and United Therapeutics.

When was Silver Creek Pharmaceuticals founded?

Silver Creek Pharmaceuticals was founded in 2010.

Where is Silver Creek Pharmaceuticals' headquarters located?

Silver Creek Pharmaceuticals' headquarters is located in San Francisco, CA, US.

When was Silver Creek Pharmaceuticals' last funding round?

Silver Creek Pharmaceuticals' most recent funding round was for $9.2M (USD) in February 2022.

How much has Silver Creek Pharmaceuticals raised to-date?

As of Feb 11, 2022, Silver Creek Pharmaceuticals has raised a total of $29.1M (USD).

Silver Creek Pharmaceuticals - Classification

Technology
  • Biotech
Geographic Exposure
  • Americas
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Therapeutics
Tags
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 13 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified